These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30402841)

  • 1. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression.
    Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1.
    Zhang GD; Gai PZ; Liao GY; Li Y
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3602-3610. PubMed ID: 31114984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
    Li SJ; Wang L; Sun ZX; Sun SJ; Gao J; Ma RL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2768-2776. PubMed ID: 31002127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma.
    Xing Y; Sun X; Li F; Jiang X; Jiang A; Li X; Lv R; Shao L
    J Int Med Res; 2021 Jun; 49(6):3000605211013548. PubMed ID: 34187214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
    Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
    Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1.
    Song C; Xiong Y; Liao W; Meng L; Yang S
    J Cell Physiol; 2019 Aug; 234(8):12910-12917. PubMed ID: 30536843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
    Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
    Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ; Sui MH; Sun ZX; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1.
    Yu J; Hong JF; Kang J; Liao LH; Li CD
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3402-3411. PubMed ID: 28829501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
    Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
    Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
    J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.
    Zhang Y; Dai J; Deng H; Wan H; Liu M; Wang J; Li S; Li X; Tang H
    Br J Cancer; 2015 Jan; 112(2):365-74. PubMed ID: 25422913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis.
    Xu S; Jia G; Zhang H; Wang L; Cong Y; Lv M; Xu J; Ruan H; Jia X; Xu P; Wang Y
    Life Sci; 2021 Jan; 264():118636. PubMed ID: 33148416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.